Clinical trials
Completed Pulmonary Disease, Chronic Obstructive trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
428 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 4 |
| 2002 | 6 |
| 2003 | 9 |
| 2004 | 5 |
| 2005 | 12 |
| 2006 | 20 |
| 2007 | 20 |
| 2008 | 20 |
| 2009 | 16 |
| 2010 | 23 |
| 2011 | 39 |
| 2012 | 29 |
| 2013 | 21 |
| 2014 | 31 |
| 2015 | 24 |
| 2016 | 33 |
| 2017 | 24 |
| 2018 | 18 |
| 2019 | 17 |
| 2020 | 14 |
| 2021 | 9 |
| 2022 | 12 |
| 2023 | 12 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 428 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 72 |
| AstraZeneca | 52 |
| Imperial College London | 30 |
| Boehringer Ingelheim | 21 |
| Novartis Pharmaceuticals | 18 |
| Chiesi Farmaceutici S.p.A. | 17 |
| Guy's and St Thomas' NHS Foundation Trust | 8 |
| University of Dundee | 7 |
| Pfizer | 6 |
| University of Leicester | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Disease, Chronic Obstructive | 428 |
| Asthma | 46 |
| Emphysema | 17 |
| Bronchitis, Chronic | 13 |
| Lung Diseases | 13 |
| Dyspnea | 11 |
| Inflammation | 9 |
| Respiration Disorders | 9 |
| Lung Diseases, Obstructive | 8 |
| Respiratory Aspiration | 8 |
Trials
Showing 1 to 25 of 428. Each trial links to its page on Pharma Observatory.
328 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.